Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics

Abstract

Successful applications and clinical development with the drug conjugate approaches are discussed. On the other hand, the reasons of why the nanoparticle approaches are not as far in development are analyzed.